GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Al-Mansour Pharmaceutical Industries (IQS:IMAP) » Definitions » Interest Expense

Al-Mansour Pharmaceutical Industries (IQS:IMAP) Interest Expense : ع.د Mil (TTM As of . 20)


View and export this data going back to 2004. Start your Free Trial

What is Al-Mansour Pharmaceutical Industries Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Al-Mansour Pharmaceutical Industries's interest expense for the three months ended in . 20 was ع.د 0.00 Mil. Al-Mansour Pharmaceutical Industries does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Al-Mansour Pharmaceutical Industries's Operating Income for the three months ended in . 20 was ع.د 0.00 Mil. Al-Mansour Pharmaceutical Industries's Interest Expense for the three months ended in . 20 was ع.د 0.00 Mil. Al-Mansour Pharmaceutical Industries did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Al-Mansour Pharmaceutical Industries Interest Expense Historical Data

The historical data trend for Al-Mansour Pharmaceutical Industries's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Al-Mansour Pharmaceutical Industries Interest Expense Chart

Al-Mansour Pharmaceutical Industries Annual Data
Trend
Interest Expense

Al-Mansour Pharmaceutical Industries Quarterly Data
Interest Expense

Al-Mansour Pharmaceutical Industries Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.


Al-Mansour Pharmaceutical Industries  (IQS:IMAP) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Al-Mansour Pharmaceutical Industries's Interest Expense for the three months ended in . 20 was ع.د0.00 Mil. Its Operating Income for the three months ended in . 20 was ع.د0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in . 20 was ع.د0.00 Mil.

Al-Mansour Pharmaceutical Industries's Interest Coverage for the quarter that ended in . 20 is calculated as

Al-Mansour Pharmaceutical Industries had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Al-Mansour Pharmaceutical Industries (IQS:IMAP) Business Description

Traded in Other Exchanges
N/A
Address
Abu-Graib, Opposite of Belady Milk, Baghdad, IRQ
Website
Al-Mansour Pharmaceutical Industries is a manufacturer of medicines and medical supplies. It develops pharmaceutical supplies, generic drugs, and medical supplies.

Al-Mansour Pharmaceutical Industries (IQS:IMAP) Headlines

No Headlines